MCS Compliance Bulletins
- 2021-GC -004 Fraud Waste and Abuse Annual Training 2021 April
- 2021-GC-004 Adiestramiento Anual de Fraude, Abuso y Despilfarro 2021
- 2021-GC-005 Explotacion Financiera 2021 Abril
- 2021-GC-005 Financial Exploitation 2021 April
- CA-COMP-078 First Tiers Education and Training
- MCS-POLICY-024 – Individuals Privacy Rule Rights
- MCS-POLICY-057 – Designation and Responsibilities of the Privacy Officer
- MCS-POLICY-064 – Use and or Disclosure of PHI for Marketing Purpose and Sale of PHI
- AE-2021-020 Independent Agents – Licence Requirements
- AE-2021-020 Agentes Independientes – Requisitos de Licencia
- Porqué Nuestro Servicio y Nosotros Somos A +
- ROC-CA-001 Guidance for search excluded in the new page of SAM
- Delegated Entity Compliance Tracker
- AE-2021-033 Marketing Activities for FMO Advantage Organizations
- AE-2021-033 Actividades de Mercadeo para Organizaciones FMO Advantage
- AE-2021-035 Agents and Brokers Dos and Donts
- AE-2021-035 Agentes y Corredores – Lo que debes y no debes hacer
- AE-2021-036 Enrollment without beneficiaries Consent
- AE-2021-036 Afiliacion sin consentimiento del beneficiario
- MCS Acknowledgement of Receipt Dec 2021
Compliance Bulletins
What you Need to Know About CMS’s Lead-Generation Guidelines
Confused about the October 8, 2021, Centers for FMO & Medicaid Services’ (CMS) advisory regarding the marketing of FMO Advantage (MA) and associated prescription drug (MAPD) plans? Here are a few key points to help demystify the latest update and help you comply...
October Compliance Bulletin CB0011-21
Sales and Enrollment Best Practices
Sales and Enrollment Best PracticesCB0009-21August 19, 2021DO: Take notes to refer back to & avoid asking consumer to repeat information already provided Engage the consumer throughout by asking open-ended questions and summarizing for their understanding Show a...
Referrals
ReferralsCB0007-21June 9, 2021Due to an increase in inquiries regarding referrals and referral bonuses and CMS’s updated direction advising “CMS no longer includes requirements about referral fees paid to non-agents/brokers in the FMO Communications and Marketing...
Ransomware – What is it and how to watch for it
Ransomware – What is it and how to watch for itCB0006-21May 26, 2021Ransom malware, or ransomware, is a type of malware that prevents users from accessing their system or personal files and demands ransom payment in order to regain access. The number one cause of...
Tips for Social Media
Tips for Social MediaCB0004-21April 13, 2021Here are a few reminders about the types of content you can’t post. Don’t share, repost or tag content by or with clients or followers without their express permission. Do not post disparaging, threatening, harassing,...
Keeping Information Secure While Working Remote
Keeping Information Secure While Working RemoteCB0003-21March 3, 2021During this continued time of uncertainty, while we continue to work remote, we want to be sure to remain compliant when interacting with the consumer PHI/PII. As a sales agent, consumers entrust you...
CMS News
CMS News CMS NEWS FOR IMMEDIATE RELEASE February 22, 2021 Contact: CMS Media Relations CMS Media Inquiries Attention: Agents who conduct sales in Texas CMS Offers Comprehensive Support to the State of Texas to Combat Winter Storm The Centers for FMO &...
Extra Help Program
Extra Help ProgramCB0001-21February 12, 2021As always, we thank you for your support and cooperation. For questions or comments, please email us at Compliance@NSGACommunications.com or you may call the toll-free number listed below. FOR AGENT USE ONLY. NOT...
Compliance Bulletin Videos
MCS Bulletin Archive
MCS 2017 Bulletins
Alerta Especializada de Cumplimiento; ST-045 Guía para Actividades de Mercadeo
AE-2017-002 Beneficiary Orientation Process about Durable Medical Equipment (DME)
AE-2017-002 Proceso de Orientación al Beneficiario sobre; Equipo Médico Duradero (DME)
1703-003 Guías para el Mercadeo de Productos
AE-2017-004 Elegibilidad Enfermedad Renal en Etapa Terminal (ESRD)
Alerta Especializada AE-2017-007 Prohibiciones en las Guías de Mercadeo de Medicare
MCS 2018 Bulletins
MCS-Policy-024: Individual’s Privacy Rule Rights
MCS-Policy-027: Notice of Privacy Practices Policy
MCS Policy 056: Business Associate Agreement Policy
MCS-Policy-065: Minimum Necessary Policy
CA-COMP-069 Sales Allegations Investigation Independent Agents
CA-COMP-053 Document Retention and Access
CA-COMP-078 First Tiers Education and Training
1801-006 Privacy and Security Training (English)
FDR 1801-004 MCS Code of Conduct and Compliance Program (English)
FDR 1801-004 MCS Codigo de Conducta y Programa de Cumplimiento (Español)
Adiestramiento_MCMG_2019_y_otras_regulaciones
Benefits_and_Beneficiary_Protections
CY_2019_MA_Enrollment_and_Disenrollment_Guidance
CY2019-Medicare-Communications-and-Marketing-Guidelines_Updated
MCS 2019 Bulletins
1901-001 Code of Conduct and Compliance Program Training
1901-002 Privacy and Security Training
MCS-Policy-001 Policies Procedures Code of Conduct and Compliance Program
MCS-Policy-002 Compliance Officer Compliance Committee
MCS-Policy-003 Effective Training and Education
MCS-Policy-004 Effective Lines of Communication
MCS-Policy-005 Well Publicized Disciplinary Standards
MCS-Policy-006 Effective System for Routine Monitoring and Auditing
MCS-Policy-007 Prompt Response to Compliance Issues
MCS-Policy-008 Non Retaliation and Non Intimidation
MCS-Policy-009 Employee Conflict of Interest
MCS-Policy-010 Document Retention and Access to Records Regulatory Authorities
CY2019-MCMG_Updated-090518_Section 70.1
Specialized Alert_FMO Website requirements – Amerilife
CA-COMP-061 Protocol for Prevention and Detection of Financial Exploitat
Section 504 Best Practices for Medicare Health and Drug Programs
CA-COMP-071 Medicare Compliance Dashboard
CA-COMP-011 Handling of Identified Deficiencies by Operational Areas and First Tiers Entities
CA-COMP-008 Risk Assessment and Auditing and Monitoring Work Plans
MCS 2020 Bulletins
- 2020-002 2020 Privacy and Security Training (ENG)
- 2020-001 Programa de Cumplimiento y Código de Conducta 2020
- Fraud Waste and Abuse Annual Training – 2020 English
- Fraud Waste and Abuse Annual Training – 2020 SPAN
- 2020 MCS Code of Conduct
- 2020 MCS Compliance Program
- MCS-Policy-002 Compliance Officer Compliance Committee
- MCS-Policy-004 Effective Lines of Communication
- MCS-Policy-006 Effective System for Routine Monitoring and Auditing
- MCS-Policy-007 Prompt Response to Compliance Issues
- MCS-Policy-025 Prevention and Detection of Financial Exploitation of the Elderly Cases
- MCS-Policy-027 Notice of Privacy Practices
- CA-COMP-040 Compliance Auditing and Monitoring
- MCS-Policy-056 Business Associate Agreement Policy
- MCS-Policy-061 Uses and Disclosures to Carry Out Treatment Payment or Health Care Operations Policy
- MCS-POLICY-069 Cyber and Security Incident Management Policy_7.10
- MCS-Policy-080 Uses And Disclosures For Which An Authorization Or Opportunity To Agree Or Object Is Not Required
- MCS-Policy-083 HIPAA Compliance Training
- MCS-Policy-084 Limited Data Set Data Use Agreement
- MCS-Policy-085 Use and Disclosure of PHI for Research Purposes
- MCS-Policy-086 De-identified Health Information
- MCS-Policy-087 Use and Disclosure of Sensitive Health Information
- MCS-Policy-088 HIPAA Privacy Complaints Policy
- MCS-Policy-091 HIPAA Designated Record Set Policy
- CA-COMP-071 Medicare Compliance Dashboard
- CA-COMP-011 Handling of Identified Deficiencies by Operational Areas and First Tiers Entities
- CA-COMP-008 Risk Assessment and Auditing and Monitoring
- CA-COMP-011 Handling of Identified Deficiencies by Operational Areas
- CA-COMP-039 Delegation Oversight
- CA-COMP-069 Sales Allegations Investigation Process for Independent Agents
- CA-COMP-071 Medicare Compliance Dashboard
- CA-FWA-008 Preclusion List Screening
- AE-2020-037 – Prohibited marketing activities for providers